| Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing DM Kurtz, MR Green, SV Bratman, F Scherer, CL Liu, CA Kunder, ... Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015 | 338 | 2015 |
| Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL F Vari, D Arpon, C Keane, MS Hertzberg, D Talaulikar, S Jain, Q Cui, ... Blood, The Journal of the American Society of Hematology 131 (16), 1809-1819, 2018 | 296 | 2018 |
| Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma K Jones, JP Nourse, C Keane, A Bhatnagar, MK Gandhi Clinical cancer research 20 (1), 253-264, 2014 | 154 | 2014 |
| Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma K Jones, F Vari, C Keane, P Crooks, JP Nourse, LA Seymour, D Gottlieb, ... Clinical cancer research 19 (3), 731-742, 2013 | 115 | 2013 |
| Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration JWD Tobin, C Keane, J Gunawardana, P Mollee, S Birch, T Hoang, J Lee, ... Journal of Clinical Oncology 37 (34), 3300, 2019 | 112 | 2019 |
| CD4+ Tumor infiltrating lymphocytes are prognostic and independent of R‐IPI in patients with DLBCL receiving R‐CHOP chemo‐immunotherapy C Keane, D Gill, F Vari, D Cross, L Griffiths, M Gandhi American journal of hematology 88 (4), 273-276, 2013 | 94 | 2013 |
| Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions C Lees, C Keane, MK Gandhi, J Gunawardana British journal of haematology 185 (1), 25-41, 2019 | 87 | 2019 |
| Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study C Keane, F Vari, M Hertzberg, KA Lê Cao, MR Green, E Han, JF Seymour, ... The Lancet Haematology 2 (10), e445-e455, 2015 | 86 | 2015 |
| LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma C Keane, SC Law, C Gould, S Birch, MB Sabdia, L Merida de Long, ... Blood Advances 4 (7), 1367-1377, 2020 | 80 | 2020 |
| The T-cell receptor repertoire influences the tumor microenvironment and is associated with survival in aggressive B-cell lymphoma C Keane, C Gould, K Jones, D Hamm, D Talaulikar, J Ellis, F Vari, S Birch, ... Clinical Cancer Research 23 (7), 1820-1828, 2017 | 76 | 2017 |
| EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity MK Gandhi, T Hoang, SC Law, S Brosda, K O’Rourke, JWD Tobin, F Vari, ... Blood, The Journal of the American Society of Hematology 137 (11), 1468-1477, 2021 | 73 | 2021 |
| Stem cell–based therapies for sepsis C Keane, M Jerkic, JG Laffey Anesthesiology 127 (6), 1017-1034, 2017 | 68 | 2017 |
| A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors SEK Fink, MK Gandhi, JP Nourse, C Keane, K Jones, P Crooks, ... American Journal of Transplantation 14 (11), 2577-2587, 2014 | 57 | 2014 |
| The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma K Jones, L Wockner, RM Brennan, C Keane, PK Chattopadhyay, ... Clinical & Experimental Immunology 183 (2), 206-220, 2016 | 55 | 2016 |
| EBV microRNA-BHRF1-2-5p targets the 3′ UTR of immune checkpoint ligands PD-L1 and PD-L2 AS Cristino, J Nourse, RA West, MB Sabdia, SC Law, J Gunawardana, ... Blood, The Journal of the American Society of Hematology 134 (25), 2261-2270, 2019 | 53 | 2019 |
| The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma C Keane, J Tobin, J Gunawardana, S Francis, G Gifford, S Gabrielli, A Gill, ... European journal of haematology 103 (3), 200-207, 2019 | 52 | 2019 |
| Tumor‐specific but not nonspecific cell‐free circulating DNA can be used to monitor disease response in lymphoma K Jones, JP Nourse, C Keane, P Crooks, D Gottlieb, DS Ritchie, D Gill, ... American journal of hematology 87 (3), 258-265, 2012 | 40 | 2012 |
| Homozygous FCGR3A‐158V alleles predispose to late onset neutropenia after CHOP‐R for diffuse large B‐cell lymphoma C Keane, JP Nourse, P Crooks, D Nguyen‐Van, H Mutsando, P Mollee, ... Internal Medicine Journal 42 (10), 1113-1119, 2012 | 39 | 2012 |
| Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples JP Nourse, P Crooks, C Keane, D Nguyen-Van, S Mujaj, N Ross, K Jones, ... Journal of virological methods 184 (1-2), 46-54, 2012 | 34 | 2012 |
| Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8+ T-cell epitopes D Nguyen-Van, C Keane, E Han, K Jones, JP Nourse, F Vari, N Ross, ... American journal of blood research 1 (2), 146, 2011 | 33 | 2011 |
Frank VariVerified email at imb.uq.edu.au
